TRACK-HD: both promise and disappointment

Affiliations

Comment

Karl Kieburtz et al. Lancet Neurol. 2012 Jan.

. 2012 Jan;11(1):24-5.

doi: 10.1016/S1474-4422(11)70285-X. Epub 2011 Dec 2.

¹ Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY, USA. karl.kieburtz@chet.rochester.edu

No abstract available

Comment on

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR; TRACK-HD investigators. Tabrizi SJ, et al. Lancet Neurol. 2012 Jan;11(1):42-53. doi: 10.1016/S1474-4422(11)70263-0. Epub 2011 Dec 2. Lancet Neurol. 2012. PMID: 22137354